טוען...
Thrombospondin-1 counteracts the p97 inhibitor CB-5083 in colon carcinoma cells
p97 has recently emerged as a therapeutic target for cancer due to its essential functions in protein homeostasis. CB-5083 is a first-in-class, potent and selective ATP-competitive p97 inhibitor that induces proteotoxic stress in cancer cells. Potential mechanisms regulating the sensitivity of cells...
שמור ב:
| הוצא לאור ב: | Cell Cycle |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Taylor & Francis
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7469669/ https://ncbi.nlm.nih.gov/pubmed/32423265 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1754584 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|